NEW DELHI, October 28, 2026 – Emphasizing the unparalleled scientific wealth inherent in the nation’s populace, Union Minister Dr. Jitendra Singh stated that India’s rich genetic and phenotypic diversity holds the potential to transform the country into a premier global destination for gene research in the coming years.
The Minister made these remarks while addressing an interactive session on ‘System and Synthetic Biology’ at the Emerging Science, Technology and Innovation Conclave (ESTIC) 2026, held at Bharat Mandapam in New Delhi on Tuesday.
Dr. Singh, who holds multiple portfolios including Science & Technology and Earth Sciences, highlighted that other nations are increasingly looking towards India for its unique genetic resources. He noted that this diversity provides a critical foundation for advanced research, particularly in understanding variations in disease patterns and unlocking new possibilities in healthcare solutions.
A major focal point of his address was the urgent need to build strong, indigenous domestic capabilities in gene synthesis and emerging areas of biotechnology. Dr. Singh warned that dependence on overseas suppliers for specialized research requirements often creates hurdles for Indian scientists regarding access, time, and research continuity. Establishing robust domestic ecosystems would empower researchers to pursue complex work far more efficiently.
Underlining the government’s commitment to scientific advancement, the Minister stressed the importance of strengthening support systems, urging greater industry participation and sustained funding for promising scientific endeavors. He also championed the growing convergence of disciplines, noting that the future of biotechnology requires an interdisciplinary approach blending biology, engineering, and mathematics.
Additionally, Dr. Singh highlighted recent policy shifts, such as provisions under the newly enacted SHANTI Act, which open nuclear medicine research to private-sector participation. Such legislative support, he argued, paves the way for stronger collaboration among research institutions, entrepreneurs, and the private industry to translate scientific discoveries into practical products that directly benefit society.
The session was also attended by Dr. Rajesh S. Gokhale, Secretary of the Department of Biotechnology (DBT), alongside top scientists and domain experts discussing the trajectory of synthetic biology in India.
Published by True Roots Media Network